Want to see HK:0010 full AI Analyst Report?
Top Page
Hang Lung Group
(0010)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$14.50
▲(6.07% Upside)
Action:Reiterated
Date:08/04/26
The score is primarily driven by stable financials with notably improved recent free cash flow and manageable leverage, tempered by a downshift in net income/ROE. Valuation is a positive support due to the moderate P/E and high dividend yield, while technicals are neutral-to-soft given the stock sitting below longer-term moving averages. Earnings-call commentary was mildly positive on retail/leasing and liquidity, but office weakness and dividend headroom limits cap the upside.
Positive Factors
Free cash flow strength
A sustained positive free cash flow (~HK$4.0B in 2025) provides durable capacity to fund development completions, service debt, and sustain dividends without relying on asset disposals. That resilience supports strategic investment and buffers cyclical volatility in property cycles.
Negative Factors
Mainland office weakness
A double-digit drop in Mainland office revenue reflects structural softness and heightened landlord competition. Prolonged weak office leasing compresses rental income and margins, slowing recovery in a major earnings segment and elevating vacancy and incentive risk for years.
Read all positive and negative factors
Positive Factors
Negative Factors
Free cash flow strength
A sustained positive free cash flow (~HK$4.0B in 2025) provides durable capacity to fund development completions, service debt, and sustain dividends without relying on asset disposals. That resilience supports strategic investment and buffers cyclical volatility in property cycles.
Read all positive factors
Hang Lung Group (0010) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$17.40B
Dividend Yield3.33%
Average Volume (3M)799.21K
Price to Earnings (P/E)12.1
Beta (1Y)0.80
Revenue Growth9.19%
EPS Growth-0.21%
CountryHK
Employees4,595
SectorReal Estate
Sector Strength53
IndustryReal Estate - Development
Share Statistics
EPS (TTM)1.00
Shares Outstanding1,361,618,300
10 Day Avg. Volume543,878
30 Day Avg. Volume799,214
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.21
Price to Sales (P/S)1.99
P/FCF Ratio5.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hang Lung Group Business Overview & Revenue Model
Company Description
Hang Lung Group Limited, established in 1960 and based in Central, Hong Kong, functions as an investment holding company with a primary focus on real estate development across Hong Kong and mainland China. Its operations are divided into two main ...
How the Company Makes Money
Hang Lung Group makes money primarily through its property-related operations. The largest recurring earnings typically come from property investment activities: it leases space in its commercial properties (e.g., retail malls and office premises)...
Hang Lung Group Earnings Call Summary
Earnings Call Date:Jul 31, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Jan 28, 2027
Earnings Call Sentiment Positive
The call presented a balanced but predominantly constructive picture: recurring leasing and retail operations showed healthy momentum (leasing revenue +5%, Mainland mall sales and customer metrics strong, membership growth robust), balance sheet metrics improved (net gearing down, cost of borrowing lower) and Westlake 66 and other developments delivered promising early results. Offsetting these positives were one-off accounting provisions (notably a HK$124m Wuhan SA provision) that depressed headline results, notable softness in Mainland office revenue (-12%) and temporary margin pressure from new openings and lower capitalization. Management emphasised cautious optimism, prudent accounting and a focus on quality leasing and customer engagement, with dividend resumption and ESG progress as supporting signals. Net effect: more positives than negatives but with clear near-term headwinds in offices and some non-cash provisioning risks.Positive Updates
Core leasing revenue growth
Leasing revenue increased by 5% with operating profit up 4%; core leasing business remains the main earnings driver and contributed the majority of recurring profit.
Negative Updates
One-off provision in Wuhan serviced apartment
A non-cash provision of approximately HK$124 million was taken for the Wuhan serviced-apartment (DP/SA) project, which materially skewed headline results and contributed to a reported negative 'optics' (management cited an apparent ~10% headline decline driven by this item).
Read all updates
Q2-2026 Updates
Positive
Negative
Core leasing revenue growth
Leasing revenue increased by 5% with operating profit up 4%; core leasing business remains the main earnings driver and contributed the majority of recurring profit.
Read all positive updates
Company Guidance
Management's guidance was cautiously constructive: they expect Mainland tenant sales to remain positive into H2 (management cited H1 retail trends of Q1 +24%, Q2 +9%, H1 about +6% and guided H2 to be “high single‑digit”), target Westlake 66 mall to break even by Q4 2026 with mall metrics already strong (May Golden Week avg ~120,000 daily footfall; stabilized 40k–50k; end‑June occupancy 89% with 98% commitment; 250 stores, ~100 first‑to‑market) and expect Westlake office occupancy to reach ~70% by end‑2027; key openings include Curio Wuxi (~Sept 2026), Mandarin Oriental (Q1 2027) and Kimpton Xujiahui (H2 2027), and Phase‑2 will expand GFA to ~150,000 sqm. On finances they flagged continued strength and flexibility: net gearing ~31.6%, average borrowing cost ~3.7%, ~50% of debt RMB‑denominated, average debt maturity ~3 years, ~HK$18bn unused facilities, 69% of debt maturing in >2 years, and finance‑cost capitalization expected to fall to ~30% for 2026. The Board resumed a cash dividend (no scrip this round), intends a progressive approach and signaled limited near‑term risk of a cut given current payout levels and balance‑sheet buffers.Hang Lung Group Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
64
Positive
Cash Flow
70
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.42B | 11.76B | 11.01B | 10.94B | 10.93B |
| Gross Profit | 6.69B | 6.83B | 7.92B | 7.68B | 7.82B |
| EBITDA | 6.31B | 5.21B | 7.20B | 7.08B | 7.26B |
| Net Income | 1.37B | 1.61B | 2.81B | 2.72B | 2.59B |
Balance Sheet | |||||
| Total Assets | 236.23B | 234.97B | 231.45B | 226.54B | 238.03B |
| Cash, Cash Equivalents and Short-Term Investments | 6.79B | 10.82B | 6.34B | 5.79B | 9.14B |
| Total Debt | 55.37B | 58.06B | 50.97B | 46.25B | 46.22B |
| Total Liabilities | 80.97B | 82.28B | 76.54B | 71.33B | 73.54B |
| Stockholders Equity | 98.88B | 95.78B | 94.36B | 92.82B | 95.84B |
Cash Flow | |||||
| Free Cash Flow | 4.02B | 5.04B | 3.91B | 378.00M | -1.14B |
| Operating Cash Flow | 4.32B | 5.21B | 4.02B | 3.10B | 1.74B |
| Investing Cash Flow | -2.31B | -3.07B | -2.85B | -3.20B | -1.44B |
| Financing Cash Flow | -6.13B | 2.38B | -566.00M | -4.25B | 1.82B |
Hang Lung Group Technical Analysis
Negative
13.67
Price Trends
13.16
Negative
14.18
Negative
14.54
Negative
Market Momentum
-0.13
Positive
35.11
Neutral
9.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0010, the sentiment is Negative. The current price of 13.67 is above the 20-day moving average (MA) of 13.26, above the 50-day MA of 13.16, and below the 200-day MA of 14.54, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 35.11 is Neutral, neither overbought nor oversold. The STOCH value of 9.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0010.
Hang Lung Group Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$131.01B | 22.89 | 1.76% | 4.17% | 2.00% | -10.22% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | HK$17.40B | 12.13 | 1.41% | 6.29% | 9.19% | -0.21% | |
58 Neutral | HK$11.70B | -7.01 | -3.14% | 7.00% | 80.71% | 4.60% | |
44 Neutral | HK$1.18B | -0.45 | -32.64% | 4.36% | 26.67% | -19.82% | |
41 Neutral | HK$645.97M | 0.05 | 392.34% | ― | -34.82% | ― | |
40 Underperform | HK$17.58B | -1.29 | -6.66% | ― | -68.23% | 29.26% |
* Real Estate Sector Average
HK:0010
Hang Lung Group
12.61
-0.40
-3.07%
HK:0041
Great Eagle Holdings
15.49
1.93
14.21%
HK:0012
Henderson Land Development Co
26.78
0.97
3.77%
HK:0017
New World Development
6.88
0.50
7.84%
HK:3377
Sino-Ocean Group Holding
0.05
-0.07
-57.26%
HK:0978
China Merchants Land Limited
0.24
-0.08
-24.76%
Hang Lung Group Corporate Events
Hang Lung Group Declares HKD 0.21 Interim Dividend for First Half of 2026
Jul 31, 2026
Hang Lung Group Limited has declared an interim ordinary cash dividend of HKD 0.21 per share for the six months ended 30 June 2026, payable in Hong Kong dollars. The announcement underscores the company’s continued commitment to returning ca...
Hang Lung Group Sets September CEO Transition With Weber Lo Moving to Advisory Role
Jul 31, 2026
Hang Lung Group and Hang Lung Properties have announced a planned leadership transition, appointing a new Chief Executive Officer Designate and Executive Director who will join the group on September 7, 2026 and assume the CEO role from October 1,...
Hang Lung Group Strengthens Governance With New Committee Appointment
Jul 31, 2026
Hang Lung Group Limited has appointed its Chair and Executive Director, Adriel Chan, as a member of the company’s Nomination and Remuneration Committee with immediate effect, adding to his existing role on the equivalent committee of its lis...
Hang Lung Group Clarifies Board and Committee Structure
Jul 31, 2026
Hang Lung Group Limited has updated its board composition and delineated the roles and functions of its directors, naming Adriel Chan as chair, Weber Wai Pak Lo as chief executive officer, and Kenneth Ka Kui Chiu as chief financial officer. The bo...
Hang Lung Group Releases 2026 Interim Results Disclosure
Jul 31, 2026
Hang Lung Group Limited has released its 2026 interim results, providing investors with an update on the company’s performance for the first half of the year. The announcement includes financial highlights, a review of operations, consolidat...
Hang Lung Group Sets July 31 Board Meeting to Approve Interim Results
Jul 2, 2026
Hang Lung Group Limited has scheduled a meeting of its board of directors for July 31, 2026, in Hong Kong. The property-focused company, listed under stock code 00010, will review the interim results for the six months ended June 30, 2026, for the...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.